glp-1 and lupus Receptor Agonists Reduce Cardiovascular Kidney Risks in Patients with Type 2 Diabetes: Study Does Ozempic Help With Lupus?

doi: 10.2337/dc09-S340

Zhang Y, Rahematpura S, Ragnini KH, Moreno A, Stecyk KS, Kahng MW, Milliken BT, Hayes MR, Doyle RP, Schmidt HD

Gastrointestinal intolerance, particularly nausea and vomiting, may affect adherence despite their tendency to diminish over time (Liu et al., 2022)

The PKPD model recapitulates longitudinal weight loss data from three randomized, doubleblind, controlled trials of subcutaneous semaglutide

Semaglutide, marketed as Ozempic (for diabetes) and Wegovy (for weight management), is a GLP-1 receptor agonist that has been approved by the FDA for both type 2 diabetes and chronic weight management